Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia
Archives of Disease in ChildhoodPublished 1 August 1998Open access
N H Birkebak, Niels Clausen
Citations64
SJR quartileQ1
SJR score0.97
SNIP1.16
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
height and body mass index standard deviation scores up to 20 years after treatment for acute lymphoblastic leukaemia and chemotherapy alone might be persisting risk factors for obesity even after final height has been attained in patients treated for childhood ALL.
Abstract
Chemotherapy combined with cranial irradiation and chemotherapy alone might be persisting risk factors for obesity even after final/height has been attained in patients treated for childhood ALL. Chemotherapy is a risk factor for reduced final height only when administered in combination with cranial irradiation. These problems need to be recognised and dealt with at follow up examination.
Keywords
Medicine
PubMedBody Mass Index variations: centiles from birth to 87 years.
1,153 Citations1991Marie‐Françoise Rolland‐Cachera, Tim Cole +4 more
Graphs for these and four other percentiles are plotted against age, and two other graphs summarising the variation and skewness of the Wt/Ht2 distribution are provided to calculate exact percentiles and Z-scores for individuals.
Acta PaediatricaPhysical growth from birth to 16 years and longitudinal outcome of the study during the same age period
268 Citations1976P Karlberg, J Taranger +6 more
Physical growth of 212 randomly selected Swedish urban children has been investigated from birth to sixteen years as part of a prospective longitudinal study of growth and development, and a secular trend was established, while there was good agreement with other contemporary Swedish investigations.
The LancetGROWTH FAILURE AND GROWTH-HORMONE DEFICIENCY AFTER TREATMENT FOR ACUTE LYMPHOBLASTIC LEUKAEMIA
202 Citations1987JudyA. Kirk, MichaelM. Stevens +7 more
In a study of 77 children who had been treated for acute lymphoblastic leukaemia with an LSA2L2 (Memorial Sloan-Kettering) chemotherapy protocol plus radiotherapy as cranial prophylaxis, growth was examined and Cranial irradiation is probably the most important causative factor in the development of GH deficiency in survivors of ALL.
The Journal of PediatricsHigh incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood
186 Citations1995Mohamed Didi, E Didcock +4 more
It is concluded that approximately half the survivors of leukemia in childhood become obese young adults and should be advised regarding a more active lifestyle and a healthy diet in an attempt to reduce the incidence of obesity.
The Journal of PediatricsFinal height after treatment for childhood acute lymphoblastic leukemia: Comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation
182 Citations1993Charles A. Sklar, Ann Mertens +7 more
Although modern regimens for acute lymphoblastic leukemia appear overall to have only a modest impact on final height, patients, especially girls, treated with 1800 cGy CRT at a young age remain at risk for clinically significant growth failure.
The LancetGROWTH IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKAEMIA
163 Citations1988Peter Clayton, P.H. Morris-Jones +2 more
In most of these children the mean loss of height over ten years was not sufficiently great to justify long-term growth hormone (GH) therapy, and chemotherapy protocols contribute to growth retardation in ALL.
Pediatric ResearchObesity after Successful Treatment of Acute Lymphoblastic Leukemia in Childhood
148 Citations1995J. E. W. M. Van Dongen-Melman, Anita C. S. Hokken‐Koelega +4 more
There was an increased prevalence of overweight after treatment for ALL which persisted over time, and patients treated with a combination of prednisone and dexamethasone had as a late effect the highest prevalence of obesity.
Archives of Disease in ChildhoodPatterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia.
137 Citations1994Isaac Odame, John Reilly +2 more
It is concluded that the obesity seen in patients treated for ALL is more pronounced in girls than boys, and that cranial irradiation is an important factor.
Journal of Clinical OncologyAbnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia.
135 Citations1991Elizabeth A. Schriock, Michael J. Schell +3 more
Medical and Pediatric OncologyHeight of children successfully treated for acute lymphoblastic leukemia: A report from the late effects study committee of childrens cancer study group
107 Citations1985Leslie L. Robison, Mark E. Nesbit +4 more
The only factor found to have significant impact on attained height percentile was exposure to craniospinal plus abdominal radiation (P less than 0.001) where there was a fivefold excess in the proportion of patients below the fifth percentile for height.
Journal of Pediatric Hematology/OncologyPrevalence of Obesity in Children After Therapy for Acute Lymphoblastic Leukemia
87 Citations1986Paulus Zee, Chen‐Hsin Chen
It is indicated that the first year following cessation of therapy is a time of excessive weight gain among pediatric ALL patients.
Journal of Clinical OncologyA method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukemia.
77 Citations1992Michael J. Schell, J Ochs +2 more
Risk factors were identified for abnormally short stature including younger age and above-average height for age at diagnosis, craniospinal irradiation, and greater decrease in height SDS during antileukemic therapy and risk factors for obesity at age 18 years.
Medical and Pediatric OncologyGrowth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood
74 Citations1998Niels Birkebæk, Sanne Fisker +4 more
Endocrinological status 10-21 years after treatment for childhood acute lymphoblastic leukemia with chemotherapy and cranial irradiation is evaluated, and GH deficiency is frequently found at long-term follow-up in patients treated for childhood ALL.
Archives of Disease in ChildhoodWeight gain and height velocity during prolonged first remission from acute lymphoblastic leukaemia.
59 Citations1985C P Sainsbury, R G Newcombe +1 more
A retrospective analysis of the medical records of 86 children in prolonged remission from acute lymphoblastic leukaemia found weight gain started during treatment and persisted into the remission years, and values of weight adjusted for height did not return to values found before treatment until eight years after diagnosis.
Archives of Disease in ChildhoodImpaired pubertal growth in acute lymphoblastic leukaemia.
59 Citations1991M Uruena, R Stanhope +2 more
The data suggest that girls treated at less than 7 years of age have a severe impairment of pubertal growth, which is probably a combination of the dual endocrinopathy of premature puberty and growth hormone insufficiency.
Acta PaediatricaNormal final height after treatment for acute lymphoblastic leukemia without irradiation
52 Citations1994Kirsten Holm, Karsten Nysom +2 more
In children treated for acute lymphoblastic leukemia, chemotherapy exerted a negative influence on growth, but catch‐up occurred within 2 years after cessation of therapy, resulting in normal final height and body proportions.
Medical and Pediatric OncologyCerebral irradiation causes blunted pubertal growth in girls treated for acute leukemia
38 Citations1994Christian Moëll, Ildikó Márky +5 more
Growth and growth hormone levels should be evaluated several years after CNS irradiation, and treatment with GH and/or luteinizing hormone releasing hormone (LHRH) analogues may be considered.
Archives of Disease in ChildhoodHeight and lymphoblastic leukaemia.
33 Citations1983J Broomhall, R. M. May +2 more
Children with untreated lymphoblastic leukaemia proved to be significantly taller than the normal population as a group, which gives support to the theory that growth hormone or a somatomedin may be involved in the development of the disease.
Acta PaediatricaHigh‐dose methotrexate causes short‐term suppression of growth in rabbits
17 Citations1995Christian Moëll, Stanislaw Garwicz
Bone growth in rabbits was measured using roentgen stereophotogrammetric analysis (RSA), a method for accurate measurement of the distance between metallic markers inserted into long bones, and the effect of Mtx on growth was discernible only at very high doses.
Archives of Disease in ChildhoodPatterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia.
16 Citations1995J Warner, John W Gregory +1 more
PubMedAuxologic data and hormonal profile in long-term survivors of childhood acute lymphoid leukemia.
10 Citations1993Catherine Dacou‐Voutetakis, Kitra +4 more